美东时间2020年5月22日,ZNTL股价今开40.2900美元,盘中最高41.3800美元,盘中最低37.6900美元,股价收跌2.42%,跌0.9700点,报39.0700美元

ZNTL简介

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It use its highly efficient drug discovery engine, which it refer to as its Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believe could result in potentially differentiated product profiles. Its discovery engine combines its extensive experience and capabilities across cancer biology and medicinal chemistry.